Growth Metrics

Kyverna Therapeutics (KYTX) Leases (2023 - 2026)

Kyverna Therapeutics posted quarterly Leases of $198000.0 for Q1 2026, down 67.16% year-on-year from $603000.0 in Q1 2025, and down 35.08% on a QoQ basis from $305000.0 in Q4 2025.

Kyverna Therapeutics (KYTX) has 4 years of Leases data on file, last reported at $198000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Leases fell 67.16% year-over-year to $198000.0; the trailing twelve-month figure through Mar 2026 stood at $198000.0 (down 67.16% YoY), and the FY2025 full-year result was $305000.0, down 63.73% from the prior year.
  • Leases for Q1 2026 stood at $198000.0, down from $305000.0 in the prior quarter.
  • Across five years, Leases topped out at $8.5 million in Q1 2024 and bottomed at $198000.0 in Q1 2026.
  • The 4-year median for Leases is $959500.0 (2024), against an average of $3.1 million.
  • Peak annual rise in Leases reached 300.46% in 2025, while the deepest fall reached 95.32% in 2025.
  • A 4-year view of Leases shows it stood at $6.5 million in 2023, then sank by 87.05% to $841000.0 in 2024, then tumbled by 63.73% to $305000.0 in 2025, then tumbled by 35.08% to $198000.0 in 2026.
  • The last three Leases figures came in at $198000.0 (Q1 2026), $305000.0 (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 61,822.50
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 189.30 Mn
10 Kyverna Therapeutics 497.98 Mn 265.03 Mn - 198,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 198,000.00
Dec 31, 2025 305,000.00
Sep 30, 2025 4.32 Mn
Jun 30, 2025 366,000.00
Mar 31, 2025 603,000.00
Dec 31, 2024 841,000.00
Sep 30, 2024 1.08 Mn
Jun 30, 2024 7.83 Mn
Mar 31, 2024 8.49 Mn
Dec 31, 2023 6.49 Mn